AstraZeneca beats estimates on strong emerging market sales as COVID wanes ...Middle East

AstraZeneca on Thursday beat expectations for first-quarter profit and revenue, as buoyant sales of cancer treatment Imfinzi and strong demand for its roster of drugs in emerging markets helped to offset dwindling COVID product sales. The company's sales and outlook highlight the rapid decline of its COVID vaccine, its best-selling product in 2021 at the height of the pandemic, which has struggled to compete with rival shots developed by Pfizer and Moderna.

Hence then, the article about astrazeneca beats estimates on strong emerging market sales as covid wanes was published today ( Thursday 27/04/2023 - 02:37 PM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca beats estimates on strong emerging market sales as COVID wanes )

Also on site :

• Ukraine Drone Strike Ignites Fire at Russian Oil Depot
• Somali scams expose a toxic brew of wokeness, welfare and immigration
• Lakkundi Gold Discovery: Modern Mystery with Historical Roots